BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma.
Galmiche A, Ezzoukhry Z, François C, Louandre C, Sabbagh C, Nguyen-Khac E, Descamps V, Trouillet N, Godin C, Regimbeau JM, Joly JP, Barbare JC, Duverlie G, Mazière JC, Chatelain D.
Galmiche A, et al.
Mol Cancer Res. 2010 Aug;8(8):1116-25. doi: 10.1158/1541-7786.MCR-10-0029. Epub 2010 Jul 20.
Mol Cancer Res. 2010.
PMID: 20647330